Euromonitor International
- Item successfully added to cart!
  
  Your cart is empty
  
  Check Out View Cart

Country Report

Medicated Skin Care in

Dermatologicals in Chile

Jan 2018

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

PROSPECTS

Nappy (diaper) rash treatments and antifungals reach a more mature phase

The fact that the forecast period value CAGR at constant 2017 prices is expected to be lower than that seen during the review period is mainly due to the fact that there will be no room for yearly unit price increases, and there will be no more space for sophistication. This is because some categories, such as nappy (diaper) rash treatments and antifungals, are already reaching a more mature phase.

As the birth rate is set to continue to decline, innovation will be the key driver of sustained growth in dermatologicals

Moreover, as the birth rate is declining, and this is set to continue over the forecast period, the main growth driver will be innovation, and the ability of players to add more value to products in order to differentiate themselves; thus, maintaining their volume and value sales growth.

Private label is expected to gain ground in a context of economic deceleration

In the uncertain economic context, even though private label products accounted for only a small share of value sales in 2017, it is predicted that private label will see growth in the near future; gaining ground as consumers become more price-sensitive.

COMPETITIVE LANDSCAPE

Eucerin maintains its lead in dermatologicals and maintains Beiersdorf (Chile)’s leadership in 2017

Beiersdorf (Chile) kept its competitors at a significant distance, leading dermatologicals by a long way in 2017, as the company increased sales of its star brand Eucerin in both medicated shampoos and vaginal antifungals. The success of Eucerin remained in its strong marketing campaigns, especially at points of sale, thanks to its in-store activation plan.

Laboratorios Andrómaco follows in second position

Laboratorios Andrómaco was far behind Beiersdorf Chile in dermatologicals throughout the review period, although still held a strong value share in 2017, mainly thanks to its Hipoglós and Fittig brands. Bayer de Chile followed closely in third, although both these companies saw share declines in 2017.

Private label growth remains limited, as brand recognition drives the performance of dermatologicals

Regarding the availability of private label products, these are expected to remain very limited within dermatologicals in Chile. Consumers tend to prefer branded products, and companies producing branded products such as Hipoglós, Loceryl and Vatanal focus on both the quality and efficacy of their ingredients in advertising campaigns to attract consumers’ attention.

Files are delivered directly into your account within a few minutes of purchase.

Samples

Medicated Skin Care Market Sample Report Medicated Skin Care Market Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in Chile with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Medicated Skin Care industry in Chile, our research will save you time and money while empowering you to make informed, profitable decisions.

The Medicated Skin Care in Chile market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Medicated Skin Care in Chile?
What are the major brands in Chile?
What are the most popular formats for acne treatments?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

Dermatologicals in Chile - Category analysis

HEADLINES

PROSPECTS

Nappy (diaper) rash treatments and antifungals reach a more mature phase

As the birth rate is set to continue to decline, innovation will be the key driver of sustained growth in dermatologicals

Private label is expected to gain ground in a context of economic deceleration

COMPETITIVE LANDSCAPE

Eucerin maintains its lead in dermatologicals and maintains Beiersdorf (Chile)’s leadership in 2017

Laboratorios Andrómaco follows in second position

Private label growth remains limited, as brand recognition drives the performance of dermatologicals

CATEGORY DATA

Table 1 Sales of Dermatologicals by Category: Value 2012-2017
Table 2 Sales of Dermatologicals by Category: % Value Growth 2012-2017
Table 3 NBO Company Shares of Dermatologicals: % Value 2013-2017
Table 4 LBN Brand Shares of Dermatologicals: % Value 2014-2017
Table 5 Forecast Sales of Dermatologicals by Category: Value 2017-2022
Table 6 Forecast Sales of Dermatologicals by Category: % Value Growth 2017-2022

Consumer Health in Chile - Industry Overview

EXECUTIVE SUMMARY

Overall steady value growth, despite the slowing economy

The health and wellness trend and cultural changes boost the performance of vitamins, dietary supplements and sports nutrition

Demographic changes galvanise product innovation

Primacy of pharmacy chains in OTC products

Sociodemographics, legislation and climate change will impact the development and growth of overall consumer health

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
Table 8 Life Expectancy at Birth 2012-2017

MARKET DATA

Table 9 Sales of Consumer Health by Category: Value 2012-2017
Table 10 Sales of Consumer Health by Category: % Value Growth 2012-2017
Table 11 NBO Company Shares of Consumer Health: % Value 2013-2017
Table 12 LBN Brand Shares of Consumer Health: % Value 2014-2017
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
Table 14 Distribution of Consumer Health by Format: % Value 2012-2017
Table 15 Distribution of Consumer Health by Format and Category: % Value 2017
Table 16 Forecast Sales of Consumer Health by Category: Value 2017-2022
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022

Megatrends

Country Report

Dermatologicals in Chile

New Report Guarantee

Executive Summary

New Report Guarantee

PROSPECTS

Nappy (diaper) rash treatments and antifungals reach a more mature phase

As the birth rate is set to continue to decline, innovation will be the key driver of sustained growth in dermatologicals

Private label is expected to gain ground in a context of economic deceleration

COMPETITIVE LANDSCAPE

Eucerin maintains its lead in dermatologicals and maintains Beiersdorf (Chile)’s leadership in 2017

Laboratorios Andrómaco follows in second position

Private label growth remains limited, as brand recognition drives the performance of dermatologicals

Samples

Overview

Why buy this report?

Samples (FAQs about samples):

Want to find out more about this report?

Table of Contents

Dermatologicals in Chile - Category analysis

HEADLINES

PROSPECTS

Nappy (diaper) rash treatments and antifungals reach a more mature phase

As the birth rate is set to continue to decline, innovation will be the key driver of sustained growth in dermatologicals

Private label is expected to gain ground in a context of economic deceleration

COMPETITIVE LANDSCAPE

Eucerin maintains its lead in dermatologicals and maintains Beiersdorf (Chile)’s leadership in 2017

Laboratorios Andrómaco follows in second position

Private label growth remains limited, as brand recognition drives the performance of dermatologicals

CATEGORY DATA

Consumer Health in Chile - Industry Overview

EXECUTIVE SUMMARY

Overall steady value growth, despite the slowing economy

The health and wellness trend and cultural changes boost the performance of vitamins, dietary supplements and sports nutrition

Demographic changes galvanise product innovation

Primacy of pharmacy chains in OTC products

Sociodemographics, legislation and climate change will impact the development and growth of overall consumer health

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports